The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab)

FHS
April 18, 2024
12:54 pm

The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova platform.

New approach to tau protein clearance offers hope for Alzheimer’s treatment

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human “mini-brains,” known

March 5, 2025

Ginkgo further scales back Boston real estate

This story originally appeared in STAT’s sister publication, The Boston Globe. There’s plenty of empty lab space around Greater Boston these days and a lot

February 28, 2025

Novo to test Wegovy and other obesity drugs against alcohol-related liver disease

Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments

May 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.